Internal Medicine · Buena Park, CA
NPI
1164577706
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6714 Beach Blvd
Buena Park, CA, 90621
Phone (147) 526-7787
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,473 services
Medicare patients, 2024
319
Average age 79
Drug cost, 2024
$7.8M
50,424 prescriptions
Company payments, 2025
$1,860
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Soo W Kang was code 99213 (office e&m - established), 921 times for 311 patients. In total Soo W Kang billed 1,473 services in 20 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 921 | 311 | $61.11 | $56K |
| 99212 Office E&M - Established | Office | 226 | 133 | $39.02 | $8,818 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 148 | 148 | $132.79 | $20K |
| 96372 Injection Administration | Office | 72 | 44 | $9.13 | $657 |
| 93000 Electrocardiogram | Office | 31 | 29 | $10.29 | $319 |
| 99203 Office E&M - New | Office | 22 | 22 | $65.86 | $1,449 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 13 | 13 | $94.16 | $1,224 |
By year: 2022 $150K for 2,321 services; 2023 $134K for 2,126 services; 2024 $90K for 1,473 services.
Medicare prescription drug claims, 2024
In 2024, the drug Soo W Kang prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,777 prescriptions and refills. In total Soo W Kang wrote 50,424 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,777 | 5,655 | 559 | $18K |
| Losartan Potassium Generic | 2,469 | 5,122 | 500 | $16K |
| Amlodipine Besylate Generic | 2,410 | 4,874 | 460 | $8,299 |
| Rosuvastatin Calcium Generic | 2,410 | 4,983 | 497 | $22K |
| Vascepa Icosapent Ethyl | 1,792 | 2,282 | 241 | $765K |
| Metformin Hcl Generic | 1,753 | 3,488 | 348 | $8,765 |
| Omeprazole Generic | 1,268 | 1,737 | 353 | $6,674 |
| Creon Lipase/Protease/Amylase | 1,020 | 1,200 | 208 | $1.3M |
| Levothyroxine Sodium Generic | 1,018 | 1,946 | 169 | $7,693 |
| Lidocaine Generic | 986 | 1,078 | 141 | $132K |
| Meloxicam Generic | 869 | 1,039 | 213 | $2,156 |
| Tamsulosin Hcl Generic | 845 | 1,723 | 180 | $6,961 |
| Linzess Linaclotide | 702 | 815 | 122 | $424K |
| Clopidogrel Clopidogrel Bisulfate | 694 | 1,046 | 101 | $3,144 |
| Ibuprofen Generic | 686 | 690 | 430 | $1,640 |
Brand drugs: 11,195 claims; generic drugs: 38,666 claims; opioid claims: 151.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Soo W Kang $1,860 ($1,860 in general payments such as food, travel and fees) from 20 companies. The largest payer was Ardelyx, Inc. with $237.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 10 | $237 |
| Novo Nordisk Inc NVO | 8 | $166 |
| GlaxoSmithKline, LLC. GSK | 7 | $163 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $159 |
| Vivus LLC | 8 | $143 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $140 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 7 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $109 |
| Amgen Inc. AMGN | 5 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $98.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.